MAVORIXAFOR - Food and Drug Administration
- Set ID
- 9f6bf01b-e105-402b-884b-49fd7cff49e1
- Type
- Indexing - product concept
- Effective date
- 2025-02-14
- Version
- 1
- Source
- DailyMed source
Mapped DailyMed Labels#
| Label | Relation | Manufacturer | Effective |
|---|---|---|---|
| These highlights do not include all the information needed to use XOLREMDI™ safely and effectively. See full prescribing information for XOLREMDI ® . XOLREMDI ® (mavorixafor) capsules, for oral use Initial U.S. Approval: 2024 | Product name | X4 Pharmaceuticals, Inc. | Catalent Greenville, Inc. | 2024-11-12 |